A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase.

Area of Science:

• Molecular Biology
• Cell Cycle Regulation
• Cancer Biology

Background:

• The protein p27Kip1 is a critical inhibitor of cell division, controlling cell cycle exit and reentry.
• Low p27 levels are linked to excessive cell proliferation, particularly in cancers.
• p27 regulation occurs via translation and protein turnover, with T187 phosphorylation by Cdk2 initiating proteolysis.

Purpose of the Study:

• To investigate the in vivo significance of the Cdk2-mediated p27 proteolysis pathway.
• To understand the mechanisms controlling p27 protein levels during the cell cycle.

Main Methods:

• Generation of a murine model with a mutated p27 gene (p27T187A) to block T187 phosphorylation.
• Analysis of cell proliferation and p27 protein levels in vitro and in vivo in p27T187A cells.
• Investigation of alternative p27 degradation pathways.

Main Results:

• Cells expressing p27T187A showed impaired p27 downregulation during S and G2 phases.
• This impairment resulted in a surprisingly modest effect on cell proliferation.
• Discovery of a novel, mitogen-activated proteolytic pathway degrading p27 specifically during G1.

Conclusions:

• The Cdk2-mediated phosphorylation at T187 is not the sole critical pathway for p27 degradation in vivo.
• A second, distinct proteolytic mechanism regulates p27 levels during G1 phase.
• These findings reveal a more complex regulatory network for p27 controlling cell proliferation.